366 related articles for article (PubMed ID: 8356789)
41. Analysis of alternatively spliced human immunodeficiency virus type-1 mRNA species, one of which encodes a novel tat-env fusion protein.
Furtado MR; Balachandran R; Gupta P; Wolinsky SM
Virology; 1991 Nov; 185(1):258-70. PubMed ID: 1926777
[TBL] [Abstract][Full Text] [Related]
42. Rev inhibition strongly affects intracellular distribution of human immunodeficiency virus type 1 RNAs.
Cmarko D; Bøe SO; Scassellati C; Szilvay AM; Davanger S; Fu XD; Haukenes G; Kalland KH; Fakan S
J Virol; 2002 Oct; 76(20):10473-84. PubMed ID: 12239324
[TBL] [Abstract][Full Text] [Related]
43. Replication-deficient recombinant adenoviruses expressing the human immunodeficiency virus Env antigen can induce both humoral and CTL immune responses in mice.
Bruce CB; Akrigg A; Sharpe SA; Hanke T; Wilkinson GWG; Cranage MP
J Gen Virol; 1999 Oct; 80 ( Pt 10)():2621-2628. PubMed ID: 10573155
[TBL] [Abstract][Full Text] [Related]
44. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.
Amendt BA; Si ZH; Stoltzfus CM
Mol Cell Biol; 1995 Aug; 15(8):4606-15. PubMed ID: 7623852
[TBL] [Abstract][Full Text] [Related]
45. Diminished production of human immunodeficiency virus type 1 in astrocytes results from inefficient translation of gag, env, and nef mRNAs despite efficient expression of Tat and Rev.
Gorry PR; Howard JL; Churchill MJ; Anderson JL; Cunningham A; Adrian D; McPhee DA; Purcell DF
J Virol; 1999 Jan; 73(1):352-61. PubMed ID: 9847339
[TBL] [Abstract][Full Text] [Related]
46. hnRNP E1 and E2 have distinct roles in modulating HIV-1 gene expression.
Woolaway K; Asai K; Emili A; Cochrane A
Retrovirology; 2007 Apr; 4():28. PubMed ID: 17451601
[TBL] [Abstract][Full Text] [Related]
47. The simian immunodeficiency virus (SIV) rev gene regulates env expression.
Cheng SM; Blume M; Lee SG; Hung PP; Hirsch VM; Johnson PR
J Med Primatol; 1990; 19(3-4):167-76. PubMed ID: 2231681
[TBL] [Abstract][Full Text] [Related]
48. Regulation of the human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein.
Chowdhury M; Taylor JP; Tada H; Rappaport J; Wong-Staal F; Amini S; Khalili K
Oncogene; 1990 Dec; 5(12):1737-42. PubMed ID: 2178236
[TBL] [Abstract][Full Text] [Related]
49. Genetic organization of a chimpanzee lentivirus related to HIV-1.
Huet T; Cheynier R; Meyerhans A; Roelants G; Wain-Hobson S
Nature; 1990 May; 345(6273):356-9. PubMed ID: 2188136
[TBL] [Abstract][Full Text] [Related]
50. [Regulatory mechanism of HIV gene expression].
Hatanaka M
Nihon Rinsho; 1993 Sep; 51 Suppl():43-57. PubMed ID: 8271415
[No Abstract] [Full Text] [Related]
51. A tripartite HIV-1 tat-env-rev fusion protein.
Salfeld J; Göttlinger HG; Sia RA; Park RE; Sodroski JG; Haseltine WA
EMBO J; 1990 Mar; 9(3):965-70. PubMed ID: 2178928
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of HIV-1 by a double transdominant fusion gene.
Aguilar-Cordova E; Chinen J; Donehower LA; Harper JW; Rice AP; Butel JS; Belmont JW
Gene Ther; 1995 May; 2(3):181-6. PubMed ID: 7614248
[TBL] [Abstract][Full Text] [Related]
53. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
Ding SF; Lombardi R; Nazari R; Joshi S
Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
[TBL] [Abstract][Full Text] [Related]
54. Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1.
Staffa A; Cochrane A
Mol Cell Biol; 1995 Aug; 15(8):4597-605. PubMed ID: 7623851
[TBL] [Abstract][Full Text] [Related]
55. Sequences in the rev-responsive element responsible for premature translational arrest in the human-immunodeficiency-virus-type-1 envelope.
Ellerbrok H; Serpente N; Pancino G; Vanhée C; D'Auriol L; Sitbon M; Vaquero C
Eur J Biochem; 1993 Sep; 216(2):459-67. PubMed ID: 8375384
[TBL] [Abstract][Full Text] [Related]
56. Analysis of trans-dominant mutants of the HIV type 1 Rev protein for their ability to inhibit Rev function, HIV type 1 replication, and their use as anti-HIV gene therapeutics.
Ragheb JA; Bressler P; Daucher M; Chiang L; Chuah MK; VandenDriessche T; Morgan RA
AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1343-53. PubMed ID: 8573391
[TBL] [Abstract][Full Text] [Related]
57. Human immunodeficiency virus type 1 Rev activation can be achieved without Rev-responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA.
Venkatesan S; Gerstberger SM; Park H; Holland SM; Nam Y
J Virol; 1992 Dec; 66(12):7469-80. PubMed ID: 1433526
[TBL] [Abstract][Full Text] [Related]
58. Analysis of rev gene function on human immunodeficiency virus type 1 replication in lymphoid cells by using a quantitative polymerase chain reaction method.
Arrigo SJ; Weitsman S; Rosenblatt JD; Chen IS
J Virol; 1989 Nov; 63(11):4875-81. PubMed ID: 2677405
[TBL] [Abstract][Full Text] [Related]
59. Replication of HIV type 1 in rabbit cell lines is not limited by deficiencies in tat, rev, or long terminal repeat function.
Cho S; Kindt TJ; Zhao TM; Sawasdikosol S; Hague BF
AIDS Res Hum Retroviruses; 1995 Dec; 11(12):1487-93. PubMed ID: 8679293
[TBL] [Abstract][Full Text] [Related]
60. Enhancement of humoral immunity to SIVenv following simultaneous inoculation of mice by three recombinant adenoviruses encoding SIVenv/poliovirus chimeras, Tat and Rev.
Chenciner N; Randrianarison-Jewtoukoff V; Delpeyroux F; Hanania N; Pedroza Martins L; Stratford Perricaudet L; Perricaudet M; Wain-Hobson S
AIDS Res Hum Retroviruses; 1997 Jun; 13(9):801-6. PubMed ID: 9171225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
